News Releases

Archives: Search / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014


Jan 14, 2020

Nektar Therapeutics (NASDAQ: NKTR) issued a statement today following a meeting of the Food and Drug Administration's (FDA's) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and...

Jan 7, 2020

Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is scheduled to present at the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco on...

Dec 17, 2019

Nektar Therapeutics (NASDAQ: NKTR) today announced it has appointed Myriam J. Curet, M.D., as an independent director to its Board of Directors. Dr. Curet brings three decades of experience...

Dec 9, 2019

Nektar Therapeutics (NASDAQ: NKTR) today announced three presentations at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition for its IL-15 agonist and investigational...

Dec 3, 2019

Nektar Therapeutics (NASDAQ:NKTR) announced today that John Northcott has joined the company in the newly-created position of Senior Vice President and Chief Commercial Officer. John will also...


Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide